Ocugen, Inc. (OCGN)
0.7798
+0.02
(+2.96%)
USD |
NASDAQ |
Oct 28, 16:00
0.7793
0.00 (0.00%)
After-Hours: 16:42
Ocugen Total Return Price : 0.7798 for Oct. 28, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| October 27, 2026 | 0.7574 |
| October 26, 2026 | 0.7084 |
| October 23, 2026 | 0.7397 |
| October 22, 2026 | 0.79 |
| October 21, 2026 | 0.8151 |
| October 20, 2026 | 0.8125 |
| October 19, 2026 | 0.7873 |
| October 16, 2026 | 0.7803 |
| October 15, 2026 | 0.8137 |
| October 14, 2026 | 0.8412 |
| October 13, 2026 | 0.8854 |
| October 12, 2026 | 0.9472 |
| October 09, 2026 | 0.9555 |
| October 08, 2026 | 0.9774 |
| October 07, 2026 | 1.00 |
| October 06, 2026 | 1.04 |
| October 05, 2026 | 1.04 |
| October 02, 2026 | 1.02 |
| October 01, 2026 | 1.00 |
| September 30, 2026 | 1.03 |
| September 29, 2026 | 1.09 |
| September 28, 2026 | 1.03 |
| September 25, 2026 | 1.02 |
| September 24, 2026 | 1.00 |
| September 23, 2026 | 1.00 |
| Date | Value |
|---|---|
| September 22, 2026 | 1.04 |
| September 21, 2026 | 1.03 |
| September 18, 2026 | 1.06 |
| September 17, 2026 | 1.03 |
| September 16, 2026 | 0.9984 |
| September 15, 2026 | 0.9935 |
| September 14, 2026 | 1.06 |
| September 11, 2026 | 1.02 |
| September 10, 2026 | 1.025 |
| September 09, 2026 | 1.065 |
| September 08, 2026 | 1.33 |
| September 04, 2026 | 1.36 |
| September 03, 2026 | 1.35 |
| September 02, 2026 | 1.32 |
| September 01, 2026 | 1.33 |
| August 31, 2026 | 1.33 |
| August 28, 2026 | 1.32 |
| August 27, 2026 | 1.37 |
| August 26, 2026 | 1.41 |
| August 25, 2026 | 1.40 |
| August 24, 2026 | 1.36 |
| August 21, 2026 | 1.39 |
| August 20, 2026 | 1.39 |
| August 19, 2026 | 1.48 |
| August 18, 2026 | 1.34 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 20.30 |
| Anika Therapeutics, Inc. | 21.51 |
| Gilead Sciences, Inc. | 159.22 |
| MannKind Corp. | 3.435 |
| Nektar Therapeutics | 38.53 |